EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lowering the C‐Reactive Protein ( CRP ) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis

Amirah Etchegaray, Naeman Goetz iD, Katherine Hanigan, Jennifer Phillips, Rina Kumar, George Tambakis, Graham Radford-Smith, Gareth Walker iD, Anthony Croft iD

Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 985-1000

DOI: 10.1111/apt.70825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 18.07.2026. Verfasst von Amirah Etchegaray und 8 weiteren Autor:innen. Beteiligte Einrichtung: Royal Brisbane and Women's Hospital, Brisbane, Australia. Hauptthemen laut MEDLINE: C-Reactive Protein, Colitis, Ulcerative, Adrenal Cortex Hormones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Real‐world data demonstrate that patients hospitalised with non‐acute severe UC (NASUC) experience intravenous corticosteroid (IVCS) failure rates approaching those of ASUC, yet no dedicated management guidelines exist.

Aims

We aimed to determine whether inpatient medical therapy and colectomy risk differ between TWC‐positive ASUC, compared to hospitalised patients who did not meet TWC (NASUC), and evaluate if a reduced CRP threshold (≥ 12 mg/L) improves case capture of high‐risk patients.

Methods

We analysed 503 consecutive acute UC admissions to a tertiary IBD centre (2015–2024). Patients not meeting TWC for ASUC were classified as NASUC. Propensity score matching (PSM) compared colectomy risk between ASUC and NASUC after adjustment for gender, endoscopic severity, disease extent and therapy on admission.

Results

A total of 145 (29%) acute UC admissions did not meet TWC for ASUC. The predominant NASUC phenotype was stool frequency ≥ 6/24 h without systemic toxicity (77%). Lowering the CRP threshold to ≥ 12 mg/L would have reclassified 26% of NASUC patients as ASUC, capturing 43% (6/14) of patients who required colectomy within 1‐year. After PSM, there was no significant difference in colectomy between ASUC and NASUC at 30‐days (9% vs. 5%, p = 0.367), 90‐days (11% vs. 5%, p = 0.158) or 1‐year (18% vs. 13%, p = 0.479) and until last follow‐up ( p = 0.77).

Conclusion

NASUC is not a benign clinical entity. Colectomy risk were comparable between ASUC and NASUC inpatients when matched for objective disease severity and treatment exposure. A reduced CRP threshold (≥ 12 mg/L) improves identification of high‐risk patients currently missed by the standard TWC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

C-Reactive ProteinColitis, UlcerativeAdrenal Cortex HormonesHumansFemalePropensity ScoreMaleColectomyMiddle AgedRisk AssessmentAcute DiseaseAdultSeverity of Illness IndexHospitalizationRetrospective Studies

Stichwörter der Autor:innen

C‐reactive proteinTruelove and Witts criteriaacute severe ulcerative colitisbiologicscolectomypropensity score matching

Substanzen

C-Reactive ProteinAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Royal Brisbane and Women's Hospital, Brisbane, Australia.
  • QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • University of Queensland, Brisbane, Australia.

ORCID-Profile: Naeman Goetz, Gareth Walker, Anthony Croft

Zitieren

APA

Etchegaray, A., Goetz, N., Hanigan, K., Phillips, J., Kumar, R., Tambakis, G., Radford-Smith, G., Walker, G., & Croft, A. (2026). Lowering the C‐Reactive Protein ( CRP ) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis. Alimentary Pharmacology & Therapeutics, 64(7), 985-1000. https://doi.org/10.1111/apt.70825

Vancouver

Etchegaray A, Goetz N, Hanigan K, Phillips J, Kumar R, Tambakis G, et al. Lowering the C‐Reactive Protein ( CRP ) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis. Alimentary Pharmacology & Therapeutics. 2026;64(7):985-1000. doi:10.1111/apt.70825

BibTeX
@article{Etchegaray2026,
  author = {Etchegaray, Amirah and Goetz, Naeman and Hanigan, Katherine and Phillips, Jennifer and Kumar, Rina and Tambakis, George and Radford-Smith, Graham and Walker, Gareth and Croft, Anthony},
  title = {Lowering the C‐Reactive Protein ( CRP ) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {7},
  pages = {985--1000},
  doi = {10.1111/apt.70825}
}
Kostenlos starten →